Dr. Wassil Nowicky — Dipl. Ing., Dr. techn., DDDr. h. c., Director of “Nowicky Pharma” and President of the Ukrainian Anti-Cancer Institute (Vienna, Austria). Has finished his study at the Radiotechnical Faculty of the Technical University of Lviv (Ukraine) with the end of 1955 with graduation to “Diplomingeniueur” in 1960 which title was nostrificated in Austria in 1975. Dr. Wassil Nowicky became the very first scientist in the development of the anticancer protonic therapy and is the inventor of the preparation against cancer with a selective effect on basis of celandine alkaloids “NSC-631570”. He used the factor that cancer cells are more negative charged than normal cells and invented the Celandine alkaloid with a positive charge thanks to which it accumulates in cancer cells very fast. Thus, Dr. Nowicky is invited as an Honorable Speaker to take part in many scientific international congresses and conferences in USA, Australia, Japan, UAE, Europe. Author of over 300 scientific articles dedicated to cancer research. Dr. Wassil Nowicky is a real member of the New York Academy of Sciences, member of the European Union for applied immunology and of the American Association for scientific progress, honorary doctor of the Janka Kupala University in Hrodno, doctor “honoris causa” of the Open international university on complex medicine in Colombo, honorary member of the Austrian Society of a name od Albert Schweizer. He has received the award for merits of National guild of pharmasists of America. the award of Austrian Society of sanitary, hygiene and public health services and others.
ACHOUR Radhouane is associate professor at faculty of medicine of Tunis-Tunisia; He has published many basic and clinical articles in relation to gynecology and obstetrics. , his research interests include Rare Diseases in gynecology and prenatal diagnosis. He serves as associate professor, Emergency Department of Gynecology and Obstetrics in maternity and neonatology center Tunis Tunisia. He also serves as member of the editorial team for: Asian Pacific Journal of Reproduction, the Global Journal of Rare Diseases, Journal of Neonatal Biology, Current pediatric research, Obstetrics and Gynecology: Open access, Pediatrics and Health Research and Member of the Science Advisory Board.
Prof. DR. Manjubala Dash, working as a professor in nursing. Specialty is obstetric and Gynaecological nursing. Had 20 years of teaching experience in the field of Nursing. She has organized National and International Conferences, workshops in the field of nursing. Had participated and presented more than 100 papers in the National and international conferences. Had published articles nearly 50 in national and international Journals. She is the co-editor of International Journal of Nursing Panorama, The Genesis, Contemporary journal of Microbiology etc. Published 3 books in the field of Midwifery and Word management. Contributed chapters for Midwifery Books. She is a National Trainer for Infant and Young Child Feeding Counselling Specialist course. Did many research project under DHR and ICMR, DST etc. main interest is in research, education, and administration. Conducted many programmes for antenatal, postnatal mothers at the community level and hospital level. She got the opportunity to deliver a talk at the International and National Conferences. She is guiding the Students of UG, PG, and Ph.D. for Research. She is a recognized guide in different university and examiner for PG and Ph.D. Students too. She has gone for conducting Inspections to various colleges by the Indian Nursing Council.
Wilson Onuigbo, a Nigerian Scientist, obtained MD from Glasgow University and Ph.D. from London University. His first paper appeared in the British Journal of Cancer as a Medical Student in 1957. By 1962, he demonstrated what is now called lymphangiogenesis. Following a flurry of papers, his biography appeared in the World Who’s Who in Science published in 1968 in the USA. By 1974, he became the world’s discoverer of the adult human living worm called Paragonimus uterobilateralis. Recently, he has hypothesized that there is an “Erythrocyte Associated Necrosis Factor (EANF)” whose identification in Translational Laboratory should become a targeted therapy for the cancer cure, provided that pharmaceutical genius materialized! He has his country’s National Order of Officer of the Order of the Niger (OON). I was awarded the special Fellowship ad euden of the Royal College of Physicians and Surgeons of Glasgow. I am also a Member, International Order of Merit, Cambridge.
Histopathology, Women Health Education